EDGAR Filing Documents for 0001012168-98-000058

Form SC 13G - Statement of Beneficial Ownership by Certain Investors:

SEC Accession No. 0001012168-98-000058

Filing Date

1998-08-28

Accepted

1998-08-28 00:00:00

Documents

Group Members

ANDREW B. FREMDERDAVID I. COHENENRIQUE H. BOILINIFARALLON CAPITAL INSTITUTIONAL PARTNERS II, L.P.FARALLON CAPITAL INSTITUTIONAL PARTNERS III, L.P.FARALLON CAPITAL INSTITUTIONAL PARTNERS, L.P.FARALLON CAPITAL MANAGEMENT LLC /ADVFARALL

SROs

NASD

Document Format Files

Seq	Description	Document	Type	Size
1	SCHEDULE 13G		SC 13G	59033
	Complete submission text file	0001012168-98-000058.txt		61629

Mailing Address ONE MARITIME PLAZA SUITE 1325 SAN FRANCISCO CA 94111

Business Address ONE MARITIME PLZ STE 1325 SAN FRANCISCO CA 94111 4154212132

FARALLON CAPITAL MANAGEMENT LLC /ADV (Filed by) CIK: 0001012168 (see all company filings)

IRS No.: 943240279 | State of Incorp.: DE | Fiscal Year End: 1231

Mailing Address

Business Address 275 ARMAND FRAPPIER BOULEVARD LAVAL PROVICE QUEBEC A8 00000 5146811744

CLINICHEM DEVELOPMENT INC (Subject) CIK: 0001054396 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-54385 | Film No.: 98700003
SIC: 2834 Pharmaceutical Preparations